← Evidence map

ArticleOncotarget2018

FoxM1 is a promising candidate target in the treatment of breast cancer.

Xiao-Feng Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

31 papers cite it

2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 29416660